Shades of the Vioxx Case for Another Drug
Interesting dilemma. Right now, they need a prospective study to determine the risks of Bextra – however, it will be several years before the results are in. So, what to do in the meantime? I probably wouldn’t prescribe this in those with cardiac risk factors – we may be going down the same Vioxx path.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
